Tag Archives: BIO

Counterfeiting and Piracy put 2.5 million legitimate jobs at risk each year.

Interesting study out of the International Chamber of Commerce stating that the global economic and social impacts of counterfeiting and piracy will reach US$1.7 trillion by 2015 and put 2.5 million legitimate jobs at risk each year.  This builds off a previous OECD study and uses the same formulas.  Other Highlights: -G20 countries lose $77.5 billion in tax revenues, lose $25 billion to increased costs of crime, lose $18.1 billion costs of deaths related to counterfeits, Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

USPTO to Issue Proposal for “Track One” Accelerated Patent Examination in Flexible “Three Track” Patent Processing Program

In case you missed this last week, the USPTO will be issuing a Federal Register Notice requesting comments on their proposed Track One Accelerated Patent Examination requirements.  The forthcoming Federal Register notice will request comments from the public on a number of different proposed requirements for participation in Track One, including (a) the proposed fee of $4,000 for each application (to recover the full cost of resources necessary to prevent the delay of other, non-prioritized applications); Read More >

Patently BIOtech  |  1 Comment  |  Email This Post
Tags: , , , , , ,

BIO Commends Senate Judiciary Committee Passage of Patent Reform Act of 2011

BIO Commends Senate Judiciary Committee Passage of Patent Reform Act of 2011 Bipartisan, consensus-oriented approach will strengthen nation’s patent system   Washington, D.C. (February 3, 2011) – Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the following statement on the passage today of The Patent Reform Act of 2011 (S. 23) by the Senate Judiciary Committee: “BIO commends the Senate Judiciary Committee for passing The Patent Reform Act of 2011.  We appreciate the Read More >

Patently BIOtech  |  1 Comment  |  Email This Post
Tags: , , , , ,

BIO’s Intellectual Property Counsels’ Committee Spring Conference and Meeting: Seattle

Over the past eight years, BIO’s semiannual IP Counsels Committee Conference has become a popular and growing event among our members’ IP and legal professionals. Our upcoming 2011 Spring IPCC Conference in Seattle, WA on April 13-15 will be an excellent opportunity for IP professionals to hear, listen, and learn about current and projected topics related to biotechnology IP. We invite you to join us in an informal, fun and informative setting to meet fellow in-house Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , ,

Brazilian Attorney General of the Union restricts ANVISA’s role in pharmaceutical patent review

We are receiving reports from Brazil that the Brazilian Attorney General of the Union (AGU) has adopted a position restricting the role of the National Agency for Sanitary Surveillance (ANVISA) in the patenting process for pharmaceutical products and processes.  Due to a lack of clarity in the Industrial Property Law, ANVISA has used its prior consent role to reject patent applications on the basis of novelty and inventiveness which is officially the role of the Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , ,